Overexpression of the c-MET/HGF receptor in human thyroid carcinomas derived from the follicular epithelium.
about
An overview of the c-MET signaling pathwayHepatocyte Growth Factor/C-Met Axis in Thyroid Cancer: From Diagnostic Biomarker to Therapeutic TargetThe PI3K-Akt-mTOR pathway in initiation and progression of thyroid tumors.Hepatocyte growth factor/scatter factor-induced intracellular signalling.The Met oncogene and basal-like breast cancer: another culprit to watch out for?Heparin induces dimerization and confers proliferative activity onto the hepatocyte growth factor antagonists NK1 and NK2.Functions of cyclin D1 as an oncogene and regulation of cyclin D1 expression.The MET receptor tyrosine kinase in invasion and metastasis.What is New on Thyroid Cancer BiomarkersOff-target effects of c-MET inhibitors on thyroid cancer cells.Acquired resistance to BRAF inhibition induces epithelial-to-mesenchymal transition in BRAF (V600E) mutant thyroid cancer by c-Met-mediated AKT activation.c-MET as a potential therapeutic target and biomarker in cancer.Signaling pathways as specific pharmacologic targets for neuroendocrine tumor therapy: RET, PI3K, MEK, growth factors, and Notch.Progress in oncolytic virotherapy for the treatment of thyroid malignant neoplasm.Met expression is associated with poor outcome in patients with axillary lymph node negative breast carcinoma.Medullary Thyroid Cancer: Clinical Characteristics and New Insights into Therapeutic Strategies Targeting Tyrosine Kinases.Silencing of c-Met by RNA interference inhibits the survival, proliferation, and invasion of nasopharyngeal carcinoma cells.Expression and action of hepatocyte growth factor in human and bovine normal ovarian surface epithelium and ovarian cancer.Growth factor-dependent activation of alphavbeta3 integrin in normal epithelial cells: implications for tumor invasion.Non-autocrine, constitutive activation of Met in human anaplastic thyroid carcinoma cells in culture.
P2860
Q24633986-E6DFE273-CC98-40EE-997D-BFF2FFF9D0F1Q33565746-A5416345-7A4A-452E-909A-6E4DB175E806Q33770769-9F9580AC-3129-46E9-8EFE-0308F1DBC471Q33863966-400450AD-2D99-4C48-A3EA-06E93D272A5BQ34173500-FFCFD0B0-2539-4666-96AB-CBD159972DD9Q36236835-350FF182-5264-4E54-B86E-F6C0E199DBE2Q36759552-36B936FE-BE9C-49D1-9A56-9548EBC86E21Q36868644-71C63979-D3BA-4683-89F0-448AC0696B4FQ37207279-D12EF531-DA95-4C12-A52C-F2EA892DB88FQ37625880-63A61CC5-9639-43B0-888C-A053E69892F6Q37702322-922591F1-D64D-406E-9BA2-27815B6ABB19Q37962905-738CDB0F-7D4B-483D-B055-C283B6281EBDQ37985518-E0D025F1-EA94-45B1-8424-8563D6CCD188Q38264652-21955D9C-DEC0-4599-A92F-00161E85B0C2Q38466547-2E1C4A09-0706-41CB-A230-C63C6E89F123Q38683133-40D909B3-0EF2-4083-A1D4-212479C657B1Q39472980-4E11DD7E-B2C5-4AF4-AE99-CC3FC4EAA835Q42483953-568F734D-16BB-4B55-AD19-9497538B7E56Q42796734-FDBC6558-5AC9-4A90-939F-9375457F1CAAQ43201388-585A5781-8A5E-4A45-B716-531DBC2FB6EB
P2860
Overexpression of the c-MET/HGF receptor in human thyroid carcinomas derived from the follicular epithelium.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年学术文章
@wuu
1995年学术文章
@zh
1995年学术文章
@zh-cn
1995年学术文章
@zh-hans
1995年学术文章
@zh-my
1995年学术文章
@zh-sg
1995年學術文章
@yue
1995年學術文章
@zh-hant
name
Overexpression of the c-MET/HG ...... rom the follicular epithelium.
@en
Overexpression of the c-MET/HG ...... rom the follicular epithelium.
@nl
type
label
Overexpression of the c-MET/HG ...... rom the follicular epithelium.
@en
Overexpression of the c-MET/HG ...... rom the follicular epithelium.
@nl
prefLabel
Overexpression of the c-MET/HG ...... rom the follicular epithelium.
@en
Overexpression of the c-MET/HG ...... rom the follicular epithelium.
@nl
P2093
P2860
P50
P356
P1476
Overexpression of the c-MET/HG ...... from the follicular epithelium
@en
P2093
P2860
P2888
P304
P356
10.1007/BF03349722
P577
1995-02-01T00:00:00Z